NVST
Envista Holdings Corp · Healthcare · Medical - Instruments & Supplies
Momentum inputs (comparable managers):
holder breadth +7.7% ·
share flow +24.6% ·
net new positions +7.1%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 206.78K | $4.17M | n/a | n/a |
| Q2 2026 | 106 | -1 | 135.17M | $3.45B | +8 | −11 |
| Q1 2026 | 112 | +2 | 125.88M | $3.08B | +10 | −9 |
| Q4 2025 | 111 | +1 | 135.55M | $2.86B | +3 | −1 |
| Q3 2025 | 20 | 0 | 79.00M | $1.61B | +1 | −2 |
| Q2 2025 | 18 | +2 | 64.07M | $1.25B | +2 | n/a |
| Q1 2025 | 13 | -2 | 25.86M | $445.80M | n/a | −2 |
| Q4 2024 | 15 | 0 | 32.49M | $626.68M | n/a | n/a |
| Q3 2024 | 14 | +1 | 30.02M | $593.21M | +1 | n/a |
| Q2 2024 | 13 | n/a | 24.10M | $400.73M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Harris Associates (Oakmark) ✦ | 10.49M | -2.7% | $207.20M | 0.3% | ▼ Trim | 2 | SEC ↗ ×2 |
| 2 | Citadel Advisors ✦ | 6.12M | +555.6% | $121.00M | 0.1% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | Geode Capital Management ✦ (passive) | 2.90M | +2.5% | $57.23M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (passive) | 1.99M | +0.6% | $39.34M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Point72 Asset Management ✦ | 1.90M | New | $37.56M | 0.1% | New | 1 | SEC ↗ |
| 6 | Tweedy, Browne ✦ | 1.89M | -0.8% | $37.30M | 1.8% | ▼ Trim | 2 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 1.24M | -16.0% | $24.47M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 8 | Gotham Asset Management ✦ | 989.12K | +328.7% | $19.54M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 9 | Marshall Wace ✦ | 928.39K | -17.8% | $18.35M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 10 | D. E. Shaw & Co. ✦ | 608.88K | -38.9% | $12.03M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 11 | Renaissance Technologies ✦ | 601.20K | -8.3% | $11.88M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Millennium Management ✦ | 201.90K | -80.3% | $3.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 140.97K | +1.1% | $2.79M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 26.55K | -16.6% | $524,727 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $37.56M | 0.1% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 10 holders, 12.46M shares, $12.36M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 8.00K sh · $220,000
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology